Literature DB >> 19443797

Microbleeds versus macrobleeds: evidence for distinct entities.

Steven M Greenberg1, R N Kaveer Nandigam, Pilar Delgado, Rebecca A Betensky, Jonathan Rosand, Anand Viswanathan, Matthew P Frosch, Eric E Smith.   

Abstract

BACKGROUND AND
PURPOSE: Small, asymptomatic microbleeds commonly accompany larger symptomatic macrobleeds. It is unclear whether microbleeds and macrobleeds represent arbitrary categories within a single continuum versus truly distinct events with separate pathophysiologies.
METHODS: We performed 2 complementary retrospective analyses. In a radiographic analysis, we measured and plotted the volumes of all hemorrhagic lesions detected by gradient-echo MRI among 46 consecutive patients with symptomatic primary lobar intracerebral hemorrhage diagnosed as probable or possible cerebral amyloid angiopathy. In a second neuropathologic analysis, we performed blinded qualitative and quantitative examinations of amyloid-positive vessel segments in 6 autopsied subjects whose MRI scans demonstrated particularly high microbleed counts (>50 microbleeds on MRI, n=3) or low microbleed counts (<3 microbleeds, n=3).
RESULTS: Plotted on a logarithmic scale, the volumes of 163 hemorrhagic lesions identified on scans from the 46 subjects fell in a distinctly bimodal distribution with mean volumes for the 2 modes of 0.009 cm(3) and 27.5 cm(3). The optimal cut point for separating the 2 peaks (determined by receiver operating characteristics) corresponded to a lesion diameter of 0.57 cm. On neuropathologic analysis, the high microbleed-count autopsied subjects showed significantly thicker amyloid-positive vessel walls than the low microbleed-count subjects (proportional wall thickness 0.53+/-0.01 versus 0.37+/-0.01; P<0.0001; n=333 vessel segments analyzed).
CONCLUSIONS: These findings suggest that cerebral amyloid angiopathy-associated microbleeds and macrobleeds comprise distinct entities. Increased vessel wall thickness may predispose to formation of microbleeds relative to macrobleeds.

Entities:  

Mesh:

Year:  2009        PMID: 19443797      PMCID: PMC2758289          DOI: 10.1161/STROKEAHA.109.548974

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  24 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; John K Hald; Rhoda Au; Carlos S Kase; Joseph M Massaro; Charles DeCarli
Journal:  Stroke       Date:  2004-05-20       Impact factor: 7.914

3.  Pathological observations in hypertensive cerebral hemorrhage.

Authors:  C M Fisher
Journal:  J Neuropathol Exp Neurol       Date:  1971-07       Impact factor: 3.685

4.  Cerebral amyloid angiopathy: the vascular pathology and complications.

Authors:  T I Mandybur
Journal:  J Neuropathol Exp Neurol       Date:  1986-01       Impact factor: 3.685

5.  Ultrastructural features of cerebral amyloid angiopathy.

Authors:  M I Okoye; I Watanabe
Journal:  Hum Pathol       Date:  1982-12       Impact factor: 3.466

6.  Cerebral microbleeds in CADASIL.

Authors:  S A Lesnik Oberstein; R van den Boom; M A van Buchem; H C van Houwelingen; E Bakker; E Vollebregt; M D Ferrari; M H Breuning; J Haan
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

7.  Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study.

Authors:  Martin Dichgans; Markus Holtmannspötter; Jürgen Herzog; Nils Peters; Michael Bergmann; Tarek A Yousry
Journal:  Stroke       Date:  2002-01       Impact factor: 7.914

8.  Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage.

Authors:  Steven M Greenberg; Jessica A Eng; MingMing Ning; Eric E Smith; Jonathan Rosand
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

9.  Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI.

Authors:  David J Werring; Duncan W Frazer; Lucy J Coward; Nick A Losseff; Hilary Watt; Lisa Cipolotti; Martin M Brown; H Rolf Jäger
Journal:  Brain       Date:  2004-07-28       Impact factor: 13.501

10.  Risk vs benefit of anti-thrombotic therapy in ischaemic stroke patients with cerebral microbleeds.

Authors:  Yannie O Y Soo; Song Ran Yang; Wynnie W M Lam; Adrian Wong; Yu Hua Fan; Howan H W Leung; Anne Y Y Chan; Cecilia Leung; Thomas W H Leung; Lawrence K S Wong
Journal:  J Neurol       Date:  2008-12-08       Impact factor: 4.849

View more
  66 in total

1.  Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy.

Authors:  Gregory A Dierksen; Maureen E Skehan; Muhammad A Khan; Jed Jeng; R N Kaveer Nandigam; John A Becker; Ashok Kumar; Krista L Neal; Rebecca A Betensky; Matthew P Frosch; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; David H Salat; Steven M Greenberg
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

Review 2.  Imaging of Cerebral Microbleeds.

Authors:  J Linn
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

3.  Cerebral microbleeds in the elderly: a pathological analysis.

Authors:  Mark Fisher; Samuel French; Ping Ji; Ronald C Kim
Journal:  Stroke       Date:  2010-10-28       Impact factor: 7.914

Review 4.  Cerebral microbleeds and macrobleeds: should they influence our recommendations for antithrombotic therapies?

Authors:  Kellen E Haley; Steven M Greenberg; M Edip Gurol
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

5.  Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia.

Authors:  Muhammad Ayaz; Alexander S Boikov; E Mark Haacke; Daniel K Kido; Wolff M Kirsch
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

6.  Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.

Authors:  Sergi Martinez-Ramirez; Jose-Rafael Romero; Ashkan Shoamanesh; Ann C McKee; Ellis Van Etten; Octavio Pontes-Neto; Eric A Macklin; Alison Ayres; Eitan Auriel; Jayandra J Himali; Alexa S Beiser; Charles DeCarli; Thor D Stein; Victor E Alvarez; Matthew P Frosch; Jonathan Rosand; Steven M Greenberg; M Edip Gurol; Sudha Seshadri; Anand Viswanathan
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

7.  Incident risk and progression of cerebral microbleeds in healthy adults: a multi-occasion longitudinal study.

Authors:  Ana M Daugherty; Naftali Raz
Journal:  Neurobiol Aging       Date:  2017-07-18       Impact factor: 4.673

Review 8.  Emerging concepts in sporadic cerebral amyloid angiopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; M Edip Gurol; Cenk Ayata; Brian J Bacskai; Matthew P Frosch; Anand Viswanathan; Steven M Greenberg
Journal:  Brain       Date:  2017-07-01       Impact factor: 13.501

9.  Progression of Brain Network Alterations in Cerebral Amyloid Angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Grace A Riley; Li Xiong; Andreas Charidimou; Gregoire Boulouis; Alison M Ayres; Kristin Schwab; Jonathan Rosand; M Edip Gurol; Anand Viswanathan; Steven M Greenberg
Journal:  Stroke       Date:  2016-08-30       Impact factor: 7.914

10.  Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL.

Authors:  Hairong Dong; Haixia Ding; Kelly Young; Mila Blaivas; Paul J Christensen; Michael M Wang
Journal:  Stroke       Date:  2013-03-12       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.